The burden of severe asthma in childhood and adolescence: Results from the paediatric U-BIOPRED cohorts

European Respiratory Journal

Volumn 46, Issue 5, 2015, Pages 1322-1333

  Fleming, Louise ^a,b   Murray, Clare ^c   Bansal, Aruna T ^d   Hashimoto, Simone ^e   Bisgaard, Hans ^f,g   Bush, Andrew ^a,b,h,i   Frey, Urs ^j   Hedlin, Gunilla ^k   Singer, Florian ^l,m   Van Aalderen, Wim M ^e   Vissing, Nadja H ^f,g   Zolkipli, Zaraquiza ^n,o,p   Selby, Anna ^n,o,p   Fowler, Stephen ^c,q   Shaw, Dominick ^r   Chung, Kian Fan ^a,b   Sousa, Ana R ^s   Wagers, Scott ^t   Corfield, Julie ^u,v   Pandis, Ioannis ^h   Rowe, Anthony ^w   Formaggio, Elena ^x   Sterk, Peter J ^e   Roberts, Graham ^n,o,p   more..

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d Acclarogen Ltd   (United Kingdom)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ ROYAL BROMPTON HOSPITAL   (United Kingdom)

^j UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^m UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

ⁿ University of Southampton   (United Kingdom)

^o UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^p ST MARY S HOSPITAL   (United Kingdom)

^q LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^r UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^s GLAXOSMITHKLINE   (United Kingdom)

^t BIOSCI CONSULTING   (Belgium)

^u ASTRAZENECA R AND D   (Sweden)

^v Areteva Ltd   (United Kingdom)

^w Oncology R and D   (United Kingdom)

^x CromSource   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MUCOLYTIC AGENT; TOBACCO SMOKE; XANTHINE DERIVATIVE; PASSIVE SMOKING;

ADOLESCENT; AIRWAY CONDUCTANCE; AIRWAY OBSTRUCTION; ASTHMA; ATOPY; BODY MASS; CAUCASIAN; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MEGADOSE; ECZEMA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OBSERVATIONAL STUDY; ONSET AGE; PAEDIATRIC ASTHMA CAREGIVER QUALITY OF LIFE QUESTIONNAIRE; PAEDIATRIC ASTHMA QUALITY OF LIFE QUESTIONNAIRE; PASSIVE SMOKING; POLLEN ALLERGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RESPIRATORY TRACT INFLAMMATION; SCHOOL CHILD; WHEEZING; ADVERSE EFFECTS; CLINICAL TRIAL; COST OF ILLNESS; EUROPE; IMMEDIATE TYPE HYPERSENSITIVITY; MULTICENTER STUDY; PEDIATRICS; QUESTIONNAIRE; RESPIRATORY SOUNDS; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

ADOLESCENT; ADRENAL CORTEX HORMONES; ASTHMA; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; PEDIATRICS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RESPIRATORY SOUNDS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; SURVEYS AND QUESTIONNAIRES; TOBACCO SMOKE POLLUTION;

EID: 84946615672     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00780-2015     Document Type: Conference Paper

References (32)

1. ChungKF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014; 43: 343-373.
2. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368: 804-813.
3. Fitzpatrick AM, Teague WG, Meyers DA, et al. Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol 2011; 127: 382-389.
4. Just J, Gouvis-Echraghi R, Rouve S, et al. Two novel, severe asthma phenotypes identified during childhood using a clustering approach. Eur Respir J 2012; 40: 55-60.
5. H2 cytokines. J Allergy Clin Immunol 2012; 129: 974-982.
6. Hastie AT, Moore WC, Meyers DA, et al. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol 2010; 125: 1028-1036.
7. Fleming L, Tsartsali L, Wilson N, et al. Sputum inflammatory phenotypes are not stable in children with asthma. Thorax 2012; 67: 675-681.
8. Saglani S, Payne DN, Zhu J, et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med 2007; 176: 858-864.
9. O'Reilly R, Ullmann N, Irving S, et al. Increased airway smooth muscle in preschool wheezers who have asthma at school age. J Allergy Clin Immunol 2013; 131: 1024-1032.
10. Auffray C, Adcock IM, Chung KF, et al. An integrative systems biology approach to understanding pulmonary diseases. Chest 2010; 137: 1410-1416.
11. Shaw DE, Sousa AR, Fowler SJ, et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J 2015; 46: 1308-1321.
12. Wheelock CE, Goss VM, Balgoma D, et al. Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J 2013; 42: 802-825.
13. Bel EH, Sousa A, Fleming L, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011; 66: 910-917.
14. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the Asthma Control Test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59-65.
15. Liu AH, Zeiger R, Sorkness C, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007; 119: 817-825.
16. Juniper EF, Guyatt GH, Feeny DH, et al. Measuring quality of life in children with asthma. Qual Life Res 1996; 5: 35-46.
17. Juniper EF, Guyatt GH, Feeny DH, et al. Measuring quality of life in the parents of children with asthma. Qual Life Res 1996; 5: 27-34.
18. Cohen JL, Mann DM, Wisnivesky JP, et al. Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the Medication Adherence Report Scale for Asthma. Ann Allergy Asthma Immunol 2009; 103: 325-331.
19. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324-1343.
20. Szalma S, Koka V, Khasanova T, et al. Effective knowledge management in translational medicine. J Transl Med 2010; 8: 68.
21. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd Edn. Hillsdale, Lawrence Erlbaum Associates, 1988.
22. 1990 British growth data. Available from www.healthforallchildren.com/?product=lmsgrowth Date last accessed: April 26, 2015.
23. Venables WN, Ripley BD. Modern Applied Statistics with S. 4th Edn. New York, Springer, 2002.
24. Nwaru BI, Hickstein L, Panesar SS, et al. The epidemiology of food allergy in Europe: a systematic review and meta-analysis. Allergy 2014; 69: 62-75.
25. Nordlund B, Konradsen JR, Pedroletti C, et al. The clinical benefit of evaluating health-related quality-of-life in children with problematic severe asthma. Acta Paediatr 2011; 100: 1454-1460.
26. Fitzpatrick AM, Gaston BM, Erzurum SC, et al. Features of severe asthma in school-age children: atopy and increased exhaled nitric oxide. J Allergy Clin Immunol 2006; 118: 1218-1225.
27. Chipps BE, Szefler SJ, Simons FE, et al. Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma. J Allergy Clin Immunol 2007; 119: 1156-1163.
28. Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007; 119: 405-413.
29. Konradsen JR, Nordlund B, Lidegran M, et al. Problematic severe asthma: a proposed approach to identifying children who are severely resistant to therapy. Pediatr Allergy Immunol 2011; 22: 9-18.
30. Saglani S, Nicholson AG, Scallan M, et al. Investigation of young children with severe recurrent wheeze: any clinical benefit? Eur Respir J 2006; 27: 29-35.
31. Brand PL, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008; 32: 1096-1110.
32. Brand PL, Caudri D, Eber E, et al. Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J 2014; 43: 1172-1177.